Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects

被引:249
作者
Lihn, AS
Bruun, JM
He, GS
Pedersen, SB
Jensen, PF
Richelsen, B
机构
[1] Aarhus Univ Hosp, Aarhus Kommune Hosp, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus Kommunehosp, Dept Surg Gastroenterol L, DK-8000 Aarhus C, Denmark
关键词
adiponectin; IL-l beta; Gene expression; Obesity; (Human) subcutaneous adipose tissue; (Human) visceral adipose tissue;
D O I
10.1016/j.mce.2004.03.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT. suggesting subcutaneous AT to be more important for circulating adiponectin levels. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 40 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[2]   Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats [J].
Altomonte, J ;
Harbaran, S ;
Richter, A ;
Dong, HJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (08) :958-963
[3]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[6]   METABOLIC ABNORMALITIES IN VISCERAL OBESITY [J].
BJORNTORP, P .
ANNALS OF MEDICINE, 1992, 24 (01) :3-5
[7]   Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro [J].
Bruun, JM ;
Pedersen, SB ;
Richelsen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1267-1273
[8]   Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue [J].
Bruun, JM ;
Lihn, AS ;
Madan, AK ;
Pedersen, SB ;
Schiott, KM ;
Fain, JN ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (01) :E8-E13
[9]  
BRUUN JM, 2003, IN VIVO IN VITRO INV, V285, pE527
[10]   Adiponectin: More than just another fat cell hormone? [J].
Chandran, M ;
Phillips, SA ;
Ciaraldi, T ;
Henry, RR .
DIABETES CARE, 2003, 26 (08) :2442-2450